Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Trends in SARS-CoV-2 cycle threshold values in the Czech Republic from April 2020 to April 2022

D. Musalkova, L. Piherova, O. Kwasny, Z. Dindova, L. Stancik, H. Hartmannova, O. Slama, P. Peckova, J. Pargac, G. Minarik, T. Zima, AJ. Bleyer, M. Radina, M. Pohludka, S. Kmoch

. 2023 ; 13 (1) : 6156. [pub] 20230415

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

The inability to predict the evolution of the COVID-19 epidemic hampered abilities to respond to the crisis effectively. The cycle threshold (Ct) from the standard SARS-CoV-2 quantitative reverse transcription-PCR (RT-qPCR) clinical assay is inversely proportional to the amount of SARS-CoV-2 RNA in the sample. We were interested to see if population Ct values could predict future increases in COVID-19 cases as well as subgroups that would be more likely to be affected. This information would have been extremely helpful early in the COVID-19 epidemic. We therefore conducted a retrospective analysis of demographic data and Ct values from 2,076,887 nasopharyngeal swab RT-qPCR tests that were performed at a single diagnostic laboratory in the Czech Republic from April 2020 to April 2022 and from 221,671 tests that were performed as a part of a mandatory school surveillance testing program from March 2021 to March 2022. We found that Ct values could be helpful predictive tools in the real-time management of viral epidemics. First, early measurement of Ct values would have indicated the low viral load in children, equivalent viral load in males and females, and higher viral load in older individuals. Second, rising or falling median Ct values and differences in Ct distribution indicated changes in the transmission in the population. Third, monitoring Ct values and positivity rates would have provided early evidence as to whether prevention measures are effective. Health system authorities should thus consider collecting weekly median Ct values of positively tested samples from major diagnostic laboratories for regional epidemic surveillance.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23011767
003      
CZ-PrNML
005      
20241107133755.0
007      
ta
008      
230718s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-023-32953-2 $2 doi
035    __
$a (PubMed)37061534
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Musalkova, Dita $u Research Unit of Rare Diseases, Department of Paediatric and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
245    10
$a Trends in SARS-CoV-2 cycle threshold values in the Czech Republic from April 2020 to April 2022 / $c D. Musalkova, L. Piherova, O. Kwasny, Z. Dindova, L. Stancik, H. Hartmannova, O. Slama, P. Peckova, J. Pargac, G. Minarik, T. Zima, AJ. Bleyer, M. Radina, M. Pohludka, S. Kmoch
520    9_
$a The inability to predict the evolution of the COVID-19 epidemic hampered abilities to respond to the crisis effectively. The cycle threshold (Ct) from the standard SARS-CoV-2 quantitative reverse transcription-PCR (RT-qPCR) clinical assay is inversely proportional to the amount of SARS-CoV-2 RNA in the sample. We were interested to see if population Ct values could predict future increases in COVID-19 cases as well as subgroups that would be more likely to be affected. This information would have been extremely helpful early in the COVID-19 epidemic. We therefore conducted a retrospective analysis of demographic data and Ct values from 2,076,887 nasopharyngeal swab RT-qPCR tests that were performed at a single diagnostic laboratory in the Czech Republic from April 2020 to April 2022 and from 221,671 tests that were performed as a part of a mandatory school surveillance testing program from March 2021 to March 2022. We found that Ct values could be helpful predictive tools in the real-time management of viral epidemics. First, early measurement of Ct values would have indicated the low viral load in children, equivalent viral load in males and females, and higher viral load in older individuals. Second, rising or falling median Ct values and differences in Ct distribution indicated changes in the transmission in the population. Third, monitoring Ct values and positivity rates would have provided early evidence as to whether prevention measures are effective. Health system authorities should thus consider collecting weekly median Ct values of positively tested samples from major diagnostic laboratories for regional epidemic surveillance.
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a dítě $7 D002648
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a senioři $7 D000368
650    12
$a SARS-CoV-2 $x genetika $7 D000086402
650    12
$a COVID-19 $x epidemiologie $x diagnóza $7 D000086382
650    _2
$a RNA virová $x genetika $x analýza $7 D012367
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a virová nálož $7 D019562
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Piherova, Lenka $u Research Unit of Rare Diseases, Department of Paediatric and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Kwasny, Ondrej $u SPADIA LAB, Ostrava, Czech Republic
700    1_
$a Dindova, Zuzana $u SPADIA LAB, Ostrava, Czech Republic
700    1_
$a Stancik, Lubor $u SPADIA LAB, Ostrava, Czech Republic
700    1_
$a Hartmannova, Hana $u Research Unit of Rare Diseases, Department of Paediatric and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Slama, Otomar $u Faculty of Safety Engineering, Technical University of Ostrava, Ostrava, Czech Republic $u Charles University Innovations Prague, Prague, Czech Republic
700    1_
$a Peckova, Petra $u Regional Authority of the Central Bohemia Region, Prague, Czech Republic
700    1_
$a Pargac, Josef $u SPADIA LAB, Ostrava, Czech Republic
700    1_
$a Minarik, Gabriel $u Medirex Group Academy, Trnava, Slovakia
700    1_
$a Zima, Tomas $u Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and the First Faculty of Medicine of Charles University, Prague, Czech Republic
700    1_
$a Bleyer, Anthony J $u Research Unit of Rare Diseases, Department of Paediatric and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic $u Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, NC, USA
700    1_
$a Radina, Martin $u SPADIA LAB, Ostrava, Czech Republic
700    1_
$a Pohludka, Michal $u GeneSpector, Prague, Czech Republic $7 xx0103478
700    1_
$a Kmoch, Stanislav $u Research Unit of Rare Diseases, Department of Paediatric and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic. skmoch@lf1.cuni.cz $u Medirex Group Academy, Trnava, Slovakia. skmoch@lf1.cuni.cz $u Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, NC, USA. skmoch@lf1.cuni.cz $u GeneSpector, Prague, Czech Republic. skmoch@lf1.cuni.cz
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 13, č. 1 (2023), s. 6156
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37061534 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20241107133748 $b ABA008
999    __
$a ok $b bmc $g 1963922 $s 1198032
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 13 $c 1 $d 6156 $e 20230415 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20230718

Find record

Citation metrics

Logged in users only

Archiving options

Loading data ...